. Data are presented from the fifth combined vascular and peritoneal dialysis (PD) access audit. . In 2015, 53 of 62 centres in England, Wales and Northern Ireland returned data on first access for 4,032 incident haemodialysis (HD) and 1,075 incident PD recipients. . Of the 5,107 incident patients, 21.0% started PD, 30.3% started HD with an arteriovenous fistula (AVF) or graft (AVG), 28.7% with a tunnelled line (TL) and 19.9% with a non-tunnelled line (NTL). . Wide variation in definitive access use (defined as primary AVF, AVG or PD) was apparent between centres.
. Only 10 centres achieved the 60% target for AVF/ AVG use amongst incident HD recipients. . Seventeen centres achieved the 80% target for AVF/ AVG/PD use amongst prevalent dialysis recipients. . Timely presentation to a nephrologist and referral to a dialysis access surgeon were key determinants of the likelihood of definitive access: -60.0% of patients known to a nephrologist for over 90 days initiated dialysis with definitive access compared with 15.2% of those who were known to a nephrologist for 90 days or less. -Among incident HD patients who were reviewed by a surgeon three months prior to starting dialysis, AVF/AVG use was 70.9% compared with 10.0% in those who were not. . AVF/AVG use amongst incident HD recipients increased with rising age and body mass index (BMI). This was due to lower rates of PD and preemptive transplant (PTx) amongst older patients and the obese. . In centres that placed non-surgical PD catheters, 25.9% of incident renal replacement therapy (RRT) patients started PD, compared with 21.0% overall. [1] , this is the fifth annual audit that combines peritoneal and vascular access, presenting information for patients starting dialysis between 1st January and 31st December 2015.
One objective of this audit has been to highlight centre-level performance variation and explore factors that may contribute to the provision of high quality vascular and peritoneal access. For the 19th Annual Report, this chapter is expanded to allow more detailed examination of dialysis access patterns through the incorporation of UKRR data. The resulting improved data completeness allowed more detailed analysis and data presentation, for example, permitting analysis of the relationship between dialysis access and PTx. The chapter is presented in two parts: part 1 presents detailed data from the fifth multisite dialysis access No Not captured by the audit audit; and part 2 presents summary data over the five years since the annual collection was started in 2011.
The term 'established renal failure' used within this chapter is synonymous with the terms 'end stage renal failure' and 'end stage kidney disease'. These alternative terms are in widespread international use, but are less acceptable to patients.
Methods
In 2016, all adult renal centres in England, Wales and Northern Ireland were asked to provide vascular and peritoneal access data for incident (1st January to 31st December 2015) and prevalent dialysis patients. Access data for incident patients were collected at patient level, whereas centre-level data were submitted for prevalent patients. Table 12. 2 presents a full glossary of collected variables. Data were collected using Microsoft Excel spreadsheets circulated by the UKRR. Records were validated against the UKRR database to confirm that the population collected at each centre for the audit was the same as, or representative of, the incident population at that centre collected via the routine quarterly return. Data checks were made by cross-referencing with the UKRR database. Any patients identified from the UKRR as not incident to dialysis between 1st January 2015 and 31st December 2015 were excluded. For the purposes of this audit, patients were categorised as having acute kidney injury (AKI) if their access at three months was recorded as 'recovered renal function' and were therefore excluded from analysis. Patients with missing information for access at start, age and date of starting RRT were excluded from the analysis. Patients were excluded when there was no matching record in the UKRR database (patient assumed to be AKI) and when aged ,18 years. If a centre reported prevalent numbers that differed by more than 10% from those in the UKRR database, it was excluded. Cross-referencing also enabled ascertainment of mortality within three months of commencing dialysis.
Patients starting HD were grouped by type of first vascular access: arteriovenous fistula, arteriovenous graft, tunnelled dialysis line, non-tunnelled dialysis line. Patients starting PD were categorised by the insertion technique: open surgery, laparoscopic, peritoneoscopic or percutaneous. Access at three months was defined as the type of access in use at three months after starting dialysis. If a patient was no longer receiving dialysis at three months (but had not recovered renal function), the reason was recorded instead, for example, 'death' or 'transplantation'. Referral time was defined as the number of days between the date of first being seen by a renal physician (as an inpatient or outpatient) and the date of commencing dialysis. A patient was classified as presenting 'late' if they had a referral time of less than 90 days.
Access failure was defined when it was no longer usable for dialysis with the date and cause of access failure reported. For the purposes of analysis, HD access failure was grouped into five causes: maturation, mechanical, infection, other and unknown. PD technique failure was grouped into six causes: infection, catheter related, solute/water clearance, leaks/hernia, other and unknown. Access failure was censored for death, transplantation, withdrawal from RRT and elective switching of access type. It was the intention to only capture access failures relating to the first access that was performed. If the reason recorded for access failure was not related to the first type of access recorded, then the data were not included in this analysis.
Centres that reported data on PD patients in the 2014 vascular and peritoneal access audit were asked to complete a one year follow-up of their PD patients. Additional information was requested on the date of PD catheter failure, the reason for catheter failure, the number of catheters used during the year and the modality in use at one year after starting PD. Analyses that use these data are titled 'PD follow-up audit'.
For the first time this chapter includes data for PTx recipients. This reflects the amended (2015) Renal Association guidelines for planned RRT initiation, which include PTx in the audit standard (table 12.1). Where possible, these data have been included at centre level to aid in the interpretation of the effects of PTx upon rates of definitive and non-definitive dialysis access. Transplant and non-transplant centres work together to prepare patients for PTx, but for the purpose of these analyses, patients have been allocated to their most likely treatment centre (transplant or non-transplant) using the approach of Judge et al. [2] ; this is based on patient postcode and the likelihood of receiving care in a centre.
Separate and combined analyses were performed for incident HD and PD patients as appropriate. Due to the exploratory nature of the audit the analyses have been limited to descriptive statistics of frequencies, percentages and unadjusted associations between variables. Centre-to-centre performance comparisons are made in the context of varying patient demography, case mix and volume. If a centre had .50% missing returns for a particular data field, then all patients from that centre were excluded from analyses involving that data field. The data were analysed using SAS 9.3.
Part 1 -Results from the 2015 Multisite Dialysis Access audit
Of 62 centres contacted, 53 returned data on first dialysis access and data from 52 centres were used. After individual patient exclusions, 5,107 patients were included, comprising 4,032 starting HD and 1,075 starting PD (figure 12.1, 9 (7,10) 8 (6,10) 9 (6,11) 8 (7,10) 9 (7,11) 8 (7,10) 9 (7,10) 8 (6,10) 9 (7,11) 8 (7,10) Diabetes figure 12. 2), BMI (figure 12.3), PRD (figure 12.4), referral time (figure 12.5), diabetic status (figure 12.6) and surgical referral (figure 12.7). Centres with .50% missing data for a variable were excluded, as detailed in the figure legend. BMI data on PTx recipients are not presented due to low data returns, although it is recognised that very few transplant recipients will have BMI .35. Transplant data were not presented against surgical referral data because all patients who received a PTx will have received surgical review. HD and PD data are displayed separately in figure 12.7 because the surgical pathways for vascular and PD access differ. Late presenting patients were excluded from this analysis. The following observations can be made:
. Number of patients in each group in brackets. Two centres were excluded due to .50% missing diabetes data after triangulation with UKRR data PTx -pre-emptive transplant; PD -peritoneal dialysis; AVF -arteriovenous fistula; AVG -arteriovenous graft; TL -tunnelled line; NTL -non-tunnelled line Number of patients in each group in brackets. Late presenting patients were excluded from the analysis AVF -arteriovenous fistula; AVGarteriovenous graft; TL -tunnelled line; NTLnon-tunnelled line; PD -peritoneal dialysis and PTx (5.5%) were both uncommon. In renovascular disease definitive dialysis access was established in 52.6% of incident patients, whilst PTx was very rare (1.7% Variations in first dialysis access by renal centre Figure 12 .8 plots incident RRT first access method stratified by centre. Practice variation was apparent. Initiating HD via an AVF/AVG ranged between ,15% (London West, Carlisle) and .40% (Cardiff, Sheffield, Gloucester, York, Colchester). Initiating HD via a TL ranged between ,5% (Belfast) and .40% (London West, Colchester, West NI). Initiating with a PD catheter ranged between 0% (Clwyd, Colchester, Plymouth) and .40% (Derby, Newry, Carlisle). There does not seem to be a relationship between the rate of definitive access use and whether a centre is a transplant or nontransplanting centre. Table 12. 4 provides centre-level data for incident dialysis access, grouping patients by time of presentation to nephrology (early 590 or late ,90 days before initiating dialysis). Late presentation was associated with low rates of definitive access placement (15.3%). Peritoneal catheter placement accounted for 73.2% of definitive access placed in late presenting patients. Sixteen centres had no late presenting patients dialysing with definitive access at initiation. Some centres were able to establish definitive vascular access for late presenting patients, although absolute numbers of patients were small. Surgical referral was made 90 days or more before dialysis initiation for 51.2% of incident patients, and ranged between .90% (London Barts, Middlesbrough) and ,20% (Plymouth, Southend). Table 12 .5 provides centre-level data for dialysis access three months after initiation, grouping patients by time of initial presentation to nephrology (early 590 or late ,90 days before initiating dialysis). Late presentation remained associated with low rates of definitive access use at three months (15.2%) compared with early presentation (60.0%). TL was the mode of access for 62.4% of late presenting patients at three months. Definitive access was similar at initiation and three months later for late presenters and early presenters. Of early presenters, 1.8% were transplanted by three months with an overall fall in use of NTLs amongst this group. Of late presenting patients, 0.1% were transplanted by three months. Sixteen centres had no late presenting patients dialysing with definitive access at three months. A small number of centres were able to establish definitive access in at least 40% of late presenting patients by three months (Derby, London St George's, Cardiff). Table 12 .6 shows dialysis access three months after initiation, stratified by first access type. The shaded cells highlight proportions of patients who continued to use their initial dialysis access at three months. Of patients who initiated dialysis with definitive access, 86.2% continued with the same access at three months and 88.2% had definitive access or a transplant, whilst 5.9% converted to TL/NTL. Of patients who started dialysis without definitive access, 12.8% received a transplant or were dialysing with definitive access at three months. Of patients who initiated dialysis with a TL, 78.9% continued with a TL at three months and only 12.9% had converted to definitive access or a transplant. Death before three months was much more common in patients initiating dialysis with a NTL than with any other form of initial access (22.5%). Of those patients who initiated dialysis with a NTL and survived to three months, 78.3% converted to a TL. Figure 12 .9 provides a funnel plot of the percentage of patients starting HD with an AVF or AVG. Late presenting patients were excluded as a surrogate for 'unplanned dialysis initiation' as per the Renal Association guidelines (table 12. 1). This analysis shows that the majority of UK renal centres fell below the Renal Association audit standard of 560% AVF/AVG use at 'planned' HD initiation. Only ten centres achieved the target. All these centres had ,65 incident HD patients, although the majority of centres of this size failed to meet the audit standard. Figure 12 .10 depicts the percentage of incident HD patients by first access used, stratified by time between date of first access formation attempt and HD initiation. Data from patients incident to dialysis in 2014 and 2015 are included. Date of first access was collected for the first time in 2014 and has not previously been presented in analyses in this chapter. Longer duration between first attempt at forming dialysis access and first HD session was associated with greater levels of AVF/AVG use at initiation. Amongst patients for whom the first attempt at forming dialysis access was made more than one year before starting HD, 89.0% initiated with AVF/ AVG; whereas for those patients for whom the first attempt at forming dialysis access was made ,90 days before starting dialysis, 15.6% commenced HD with an AVF/AVG. The biggest increment in definitive dialysis access occurred between ,90 and 590 days. Three centres were excluded due to .50% missing data for date of first access attempt. Furthermore, the data field did not specify which access was attempted, so it cannot be assumed that first access attempt and access used on first session were the same. Missing data had a similar distribution of access use to those seen in patients for whom data were provided, suggesting no systematic tendency for early or late presenting patients to be more or less likely to have missing data.
Variations in prevalent dialysis access by renal centre Figure 12 .11 provides a funnel plot of the percentage of prevalent dialysis patients receiving PD or HD via an AVF/AVG. Seventeen centres met the Renal Association audit standard of 580% for definitive access use (thick dotted line). Thirteen centre-level exclusions were made for this analysis due to non-completion of prevalent dialysis access data and .10% differences between centre-reported and UKRR numbers of patients receiving dialysis. Figure 12 .12 depicts dialysis access for prevalent patients by centre. Wide practice variation was apparent. Rates of definitive access ranged between .90% (Derby, Birmingham Heartlands, Dorset) and ,50% (London West, Ulster). PD accounted for between .25% (Dudley, Carlisle) and ,5% (London West, London Guys) of prevalent definitive access use. Thirteen centre-level exclusions were made for this analysis due to non-completion of prevalent dialysis access data and .10% differences between centre-reported and UKRR numbers of patients receiving dialysis.
Peritoneal dialysis audit one-year follow-up by renal centre Figure 12 .13 shows RRT modality one year after commencing PD by centre. Data for this analysis came from the 2015 one year follow-up for patients incident to dialysis in 2014. Centres with 100% missing data at one year, or fewer than five PD patients were excluded. The percentage of patients remaining on PD or who were transplanted one year after initiation ranges between 10% (Stevenage) and .85% (Cambridge, Doncaster, Wrexham, Plymouth, Leeds, Salford) with an overall mean of 72.8%. Of patients continuing dialysis (i.e. censoring for death, transplant and withdrawal), 76.6% of patients starting PD continued to use this modality one year later. Figure 12 .14 depicts PD catheter insertion technique stratified by centre. The five centres reporting fewer than five patients on PD were not considered for analysis.
Surgical techniques include open and laparoscopic. Nonsurgical techniques include percutaneous and peritoneoscopic insertion. There was considerable practice variation. Seventeen centres performed non-surgical PD catheter placement, accounting for 25.9% of all catheters placed and 13 of these centres placed .50% of their PD catheters this way. Six placed .90% of their PD catheters percutaneously (Southend, Gloucester, Derby, Birmingham Heartlands, Salford, Wolverhampton). At the 17 centres that place non-surgical PD catheters, 25.9% of incident RRT patients started PD, compared with 21.0% overall. Approximately 48% percent of incident RRT patients started PD at the six centres that placed .90% of their catheters percutaneously. Figure 12 .15 displays PD catheter insertion technique by referral time. There does not appear to be a strong relationship between referral time and technique for PD catheter insertion. This suggests that the PD access referral pathway was less dependent on timely referral than the vascular access pathway. Ulster (115) Newry (108) Sund (245) Newc (361) L Barts (1, 227) Middlbr (381) Colchr (120) Belfast (205) Bradfd (255) L Kings (660) L Guys (713) Carlis (124) Sheff (670) Brightn (500) B QEH (1, 152) Cardff (583) Leic (1,019) Redng (369) Oxford (534) Salford (494) Sthend (142) Wrexm (146) L Rfree (868) Truro (188) Camb (436) Leeds (570) Bangor (100) Donc (206) Hull (443) Dudley (252) Wolve (413) Shrew (242) Nottm (473) York (189) Exeter ( Data are from the one year PD follow-up audit of patients incident to PD in 2014. PD catheter failure was censored for transplantation, elective transfer to HD or death. Of the 30 centres for which data were available, none were above the 95% limit for PD catheter failure. However, four centres were below the lower 99.9% limit, none of which reported a failed PD catheter. The average one year catheter failure rate of 13.3% is an improvement on that which was reported in previous years (20.2% in 2014). Nine centres reported peritonitis within two weeks of PD catheter insertion, with rates ranging between 1.3% and 13.0% of inserted catheters. Twentynine centres reported no cases of peritonitis within two weeks. These results should be interpreted with caution due to missing data and small numbers of patients in some centres. Figure 12 .18 shows comparative access failure by access type within three months of initiating dialysis. Data were drawn from the 2014 and 2015 Multisite Dialysis Access audits. Access failure was defined as a documented date of failure/discontinuation recorded within three months of starting dialysis, unless a centre comment indicated that it was a planned discontinuation. Failure rates appeared higher for PD than for HD access. Numbers of AVGs and peritoneoscopically inserted PD tubes were very low, hence the wide confidence intervals (CIs) for these data. There was no signal from these data to suggest that sub-types of HD or PD access were more or less likely to fail at three months. Figure 12 .19 shows causes of PD catheter access failure within one year of initiating dialysis in 112 catheters reported from the one year PD follow-up audit of patients incident to dialysis in 2014. Infection was a more frequent cause of failure for percutaneously inserted than surgically placed PD catheters and for open compared with laparoscopic insertion. No leaks or hernias were reported for percutaneously inserted or failures reported in peritoneoscopically inserted PD catheters. The relatively small number in this analysis increases the likelihood that differences in causes of failure between subgroups are due to chance. Glouc (20) Sthend (5) Derby (22) Salford (29) Wolve (33) L Kings (46) Brightn (25) Sund (9) Camb (12) Leic (49) Redng (27) Stevng (8) Bradfd (9) Liv Ain (24) Prestn (21) Sheff (16) Ports (33) L Rfree (84) Wirral (11) Basldn (8) Dudley (17) B QEH (44) Antrim (9) Bangor (8) Carlis ( Leeds (29) Middlbr (15) Newc (15) Newry (12) Nottm (31) Oxford (29) Shrew (12) Swanse (23) Truro (7) Wrexm ( Over the five years since the multisite access audit was initiated, data on a total of 23,639 incident dialysis patients have been collected. The UKRR holds data for 33,034 incident dialysis patients over this period with patient-level data on dialysis access being available for 71.6% (table 12.7). The quality and completeness of data have improved over the time that the annual audit has been running (table 12.8), although the number of centres providing data peaked in 2013. Completeness for some fields remained lower than 75% with access complications having particularly low levels of completion, although there is improvement here too.
Table 12.9 provides centre-level data for incident dialysis access, grouping patients by time of presentation to nephrology services (early 590 or late ,90 days before initiating dialysis). This table reproduces table 12.4 (which includes 2015 incident patients only) for incident dialysis patients between 2011 and 2015. Late presentation remains associated with low rates of definitive access placement compared with early presentation. Table 12 .10 provides an annual summary of rates of incident and prevalent definitive dialysis access and PTx. It shows that national performance from reporting centres has consistently fallen below Renal Association Table 12 .11 shows dialysis access three months after initiation, stratified by first access used for patients from the 2011-2015 audits. This reproduces table 12.6 (which includes 2015 patients only). As before, the majority (85.8%) of patients who initiated with definitive access continued with definitive access or had been transplanted at three months. Of patients who started dialysis without definitive access, 28.4% received a transplant or were dialysing with definitive access at three months.
Death before three months was much more common in patients initiating dialysis with a NTL than with any other form of initial access (12.7%), which is lower than the 2015 data (22.4%). None set
In 2015, audit standards were updated for AVF/AVG in incident HD patients (minimum standard reduced from 65% to 60%); incident RRT recipients (to include PD and PTx; no minimum standard set) and prevalent dialysis patients (to include PD and HD via AVF/AVG -'definitive access', minimum standard 80%). It is not entirely the same centres submitting access data each year and therefore direct year-toyear comparisons in performance are not valid. HD -haemodialysis; PD -peritoneal dialysis; AVF -arteriovenous fistula; AVG -arteriovenous graft; TL -tunnelled line; NTL -nontunnelled line; RRT -renal replacement therapy * Prevalent data were not collected in the 2011 audit informing guidance and practice improvement. Centrelevel data are provided as a surrogate of geographical variation in RRT provision. Wide variation in practice reflects the absence of a cohesive approach, despite national guidance. The insights gained from the inclusion of all information about all three RRT modalities in this chapter reflect the importance of a comprehensive approach in the exploration of trends in RRT access provision. Once again, this year's multisite dialysis access audit identifies the need for research and quality improvement initiatives to enhance dialysis access practice. The following approaches may help to generate the knowledge required to drive this process:
. Detailed practice pattern assessment of high and low-performing centres and those that have demonstrated marked improvement in their delivery of definitive access.
. Assessment of responsive pathways to PD access formation, with particular focus on the role of surgical and non-surgical insertion technique and treatment pathways that facilitate initiation of PD within 90 days. . Use of UKRR data to analyse the associations between dialysis access at initiation and outcomes beyond one year, including dialysis catheter-related complications. . Improvement in the completeness of data provision for the annual multisite dialysis access audit.
